Adient (NYSE:ADNT) Price Target Cut to $24.00 by Analysts at Barclays

Adient (NYSE:ADNT – Free Report) had its price objective trimmed by Barclays from $29.00 to $24.00 in a report issued on Thursday morning, Benzinga reports. The brokerage currently has an equal weight rating on the stock. Several other equities research analysts also recently weighed in on the company. UBS Group decreased their price target on […]

Leave a Reply

Your email address will not be published.

Previous post Manning & Napier Advisors LLC Makes New Investment in Mondelez International, Inc. (NASDAQ:MDLZ)
Next post Manning & Napier Advisors LLC Takes $46.57 Million Position in SPDR Portfolio Intermediate Term Treasury ETF (NYSEARCA:SPTI)